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Case Report
Introduction
Toxic leukoencephalopathy (TL) is suspected whenever a per-
son develops neurobehavioral symptoms, and magnetic reso-
nance imaging (MRI) reveals white matter lesions, especially 
if the lesions are widespread, confluent, and symmetric.1,2 
Diagnosing TL requires evidence of exposure to an agent with 
known white matter toxicity. It is also important to exclude 
other causes of leukoencephalopathy, such as autoimmune, 
inflammatory, or infectious white matter diseases, posterior 
reversible encephalopathy syndrome, chronic microvascular 
changes, and inherited disorders of myelin metabolism.3,4 A 
variety of chemicals can potentially cause TL, including sub-
stances of abuse (eg, heroin, opiates, amphetamines, cocaine, 
and ethanol), antineoplastic drugs (eg, methotrexate, cisplatin, 
and fluorouracil), immune modulators (eg, cyclosporine and 
interferon), and environmental toxins (eg, carbon monoxide, 
toluene, arsenic, and carbon tetrachloride).1-3 The MRI find-
ings can be highly characteristic with some of these neurotox-
ins such that one can suspect the offending agent based on MRI 
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Abstract
Toxic leukoencephalopathy (TL) is characterized by white matter disease on magnetic resonance imaging (MRI) and 
evidence of exposure to a neurotoxic agent. We describe a case of cocaine-induced TL in which extensive white matter 
disease did not preclude full recovery. A 57-year-old man with substance abuse disorder presented with a 5-day history 
of strange behavior. On admission, he was alert but had difficulty concentrating, psychomotor retardation, and diffuse 
hyperreflexia. Brain MRI revealed confluent subcortical white matter hyperintensities with restricted diffusion in some 
but not in other areas. Electroencephalography (EEG) showed mild diffuse slowing. Blood tests were normal except for 
mild hyperammonemia. Urine screen was positive for cocaine and benzodiazepine but quantitative analysis was significant 
only for cocaine. Prednisone 60-mg qd was initiated on day 4, tapered over a 5-day period, and discontinued on day 9. 
He was discharged after 3 weeks. Cognitive function returned to normal 2 weeks after discharge. Five months later, 
neurologic exam and EEG were normal and MRI showed near-100% resolution of white matter lesions. TL has been 
attributed to white matter ischemia/hypoxia resulting in demyelination/axonal injury. The clinical, EEG, and MRI findings 
and time course of recovery of our patient suggest that cocaine-induced inflammation/edema resulted in TL but not 
in ischemic/hypoxic injury. While inflammation/edema may have regressed when cocaine was discontinued, we cannot 
exclude a role for prednisone in protecting the patient from the ischemic/hypoxic sequelae of inflammation/edema. MRI 
is indispensable for diagnosing TL but EEG may provide additional useful diagnostic and prognostic information.
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results. For example, carbon monoxide neurotoxicity with 
bilateral lobar white matter lesions will also cause damage to 
the anterior globus pallidus with or without the involvement 
of the thalamus, caudate, putamen, and cerebellum (for a pic-
torial review see Refs 3 and 4). The clinical spectrum of TL is 
broad, with symptoms varying from inattention, forgetful-
ness, and personality change, to delirium and coma.1,2 Clinical 
outcome is also variable.5 Although death has been reported 
many times, survival is still the rule. Survivors may achieve 
full recovery after a short or long period of convalescence or 
continue to experience variable degrees of neurological defi-
cits.1,2,5 The earlier the offending agent is identified and dis-
continued, the better the prognosis.
Cocaine-induced TL has been reported much less fre-
quently than TL caused by other drugs of abuse, notably 
heroine and other opioids.6-18 There is apparently no signifi-
cant difference in the risk of TL between chronic cocaine 
abusers and first-time users as well as between individuals 
who inhale cocaine and those who smoke it in the form of 
crack.19 Some reported cases of cocaine-induced TL resulted 
in death or in major functional impairment.6,11,13,14,18 The 
overall mortality rate of cocaine-induced TL is about 23%.19 
Some survivors who went into remission experienced one or 
more relapses with repeat or continuous exposure to 
cocaine.8,10 At the opposite end of the spectrum are patients 
with cocaine-induced TL who experienced full recovery or 
who developed minimal residual deficits.7-9,12,16,17 Some 
received corticosteroid (unspecified), dexamethasone, or 
methylprednisolone with plasmapheresis or with intravenous 
immunoglobulins.8,10,12,17 However, there are also patients 
who were treated with corticosteroid (unspecified), methyl-
prednisolone, cyclophosphamide, and/or plasma exchange 
with poor outcome.11,13-15 Interestingly, cocaine-induced TL 
was the final diagnosis in a few patients who were initially 
thought to have neuroleptic malignant syndrome, schizo-
phrenia-induced catatonia, Susac’s syndrome, or Balo’s con-
centric sclerosis.7,11,19,20 White matter lesions have also been 
detected in the MRI of asymptomatic cocaine users.19
The variability in symptoms, MRI findings, disease sever-
ity, and clinical outcomes in the reported cases of cocaine-
induced TL may be due to the fact that cocaine is not always 
the ingredient causing TL. For example, the adulterant 
levamisole or the pasta base of cocaine have been implicated 
in the pathogenesis of TL.9-11,13,14,16 Nevertheless, even if 
cocaine were the actual cause of TL in all of the reported 
cases, the clinicopathological profile would probably still be 
heterogeneous because cocaine-induced brain injury is medi-
ated via different pathophysiological mechanisms. Some 
patients with cocaine-induced TL presented with mild symp-
toms despite evidence of severe disease on MRI.12,15 We 
describe a case of cocaine-induced TL with complete clinical 
recovery despite MRI evidence of extensive white matter 
disease. The time course of clinical recovery, electroenceph-
alographic (EEG) normalization, and resolution of MRI 
lesions suggest that cocaine-induced neuroinflammation and 
white matter edema occurred without significant demyelin-
ation and axonal injury.
Case Presentation
A 57-year-old man with substance abuse disorder was brought 
by his family to the emergency room because of strange 
behavior. Five days prior to admission, he fell off his bicycle 
and came home with a scalp laceration on the left side of the 
head. Since then, his family noticed him acting oddly. He was 
seen walking back and forth in the house between the front 
door and the back door. He emptied the ice tray and he poured 
sugar into a shopping bag for no reason. He could no longer 
perform habitual tasks, such as cooking. His family described 
his gait as slow “like a zombie.” It was also unusual for him 
not to leave the house 5 days in a row. He does not see a pri-
mary care physician. According to his family, he smoked 
tobacco regularly (2 packs/day for 40 years), consumed alco-
hol rarely, and abused marijuana and cocaine.
The patient did not complain of headache, nausea, dizzi-
ness, and so on; he thinks nothing is wrong with him. Blood 
pressure was 187/104 mm Hg, heart rate 77 beats/min, respi-
ratory rate 16 breaths/min, temperature 36.6°C, and blood 
oxygen saturation 100%. Criteria for hypertensive emer-
gency or urgency were not met. He was awake and alert with 
normal thought content and intact ability to answer ques-
tions, but his affect was flat, he was indifferent to his condi-
tion, and he exhibited psychomotor retardation. On 
neurological examination, he was oriented to self, place, and 
immediate situation, but was oblivious of the month, day, 
and year. His ability to concentrate was mildly impaired and 
he pauses frequently when speaking; nevertheless, speech 
and language function were intact. Cranial nerve functions 
and motor strength were all normal. Deep tendon reflexes 
were brisk (3+) in all extremities. Ankle clonus and Babinski 
sign were absent. Cerebellar signs were also absent. Head 
computed tomography showed mild diffuse brain atrophy. 
Blood counts and chemistry were all normal except for mild 
hyperammonemia (39 µmol/L).
He was admitted to the neurology service. Urine was 
positive for cocaine and benzodiazepine, but only cocaine 
was found significant on quantitative analysis (levamisole 
was not tested). Additional studies, including thyroid stimu-
lating hormone; folate; B12; HgbA1C; HIV; hepatitis panel; 
heavy metal screen for lead, arsenic, and mercury; and blood 
toxicology for ethanol, methanol, salicylates, acetamino-
phen, and so on, were all negative. Brain MRI revealed dif-
fuse confluent subcortical white matter hyperintensities on 
T2-FLAIR and diffusion-weighted imaging (DWI) with 
low-apparent diffusion coefficient (ADC) in some areas 
(restricted diffusion) and high ADC in other areas (T2 shine-
through effect). The cerebral cortex, cerebellum, basal gan-
glia, thalamus, and brainstem were all normal (Figure1). 
EEG showed mild diffuse slowing with inordinate amounts 
of theta waves intermixed with low-voltage beta and alpha 
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activity (Figure 2). Lumbar puncture was considered but not 
pursued because we were convinced that he has cocaine-
induced TL and we could not justify exposing him to the 
risk of brain herniation. Albeit infrequent, brain herniation 
may occur with diffuse brain edema (eg, liver failure).21
Immunosuppressive therapy in cocaine-induced TL has 
been associated with a favorable8,10,12,17 or unfavorable11,13-15 
outcome (see “Introduction”). Notwithstanding this uncer-
tainty, we chose to treat the patient with a 5-day course of 
prednisone because of the extent of his disease. Prednisone 
60-mg qd was administered on hospital day 4, tapered to 20 
mg qd over 5 days, and stopped on hospital day 9. Nutritional 
therapy and assistance with activities of daily living resulted 
in gradual normalization of mental status and behavior. After 
3 weeks in acute care, the patient was discharged to a reha-
bilitation facility. He missed his appointments and was seen 
again in clinic after 5 months. His family pointed out that his 
cognitive function returned to normal 2 weeks after he was 
discharged from acute care and at that point he started engag-
ing again in the activities of daily living. During clinic visit, 
he reported (and his family agreed) that he no longer takes 
cocaine and other drugs of abuse. Neurological examination 
and cognitive evaluation did not detect any abnormalities. 
Follow-up brain MRI showed complete absence of diffusion 
restriction and near-100% resolution of white matter hyper-
intensity (Figure 3). Follow-up EEG showed normal alpha 
rhythm posteriorly and normal beta activity anteriorly during 
wakefulness (Figure 4).
Discussion
Cocaine alters the brain’s physiology and the person’s 
behavior by binding to dopamine transporter and inhibiting 
the reuptake of dopamine and other neurotransmitters.22 
The neurotoxic effects of cocaine are, however, more com-
plex and involve a variety of mechanisms, including dopa-
mine-mediated increase in free radicals and oxidative 
stress, glutamate-mediated excitotoxicity, changes in gene 
transcription, and induction of neuroinflammation.23 In the 
case presented, chronic cocaine abuse resulted in acute TL 
with mild symptoms (disorientation to time, difficulty con-
centrating, and psychomotor retardation), mild EEG 
changes (scattered theta waves mixed with normal rhythms), 
and prominent MRI abnormalities (extensive white matter 
disease with restricted diffusion in some areas but not in 
others). Complete cognitive and functional recovery was 
achieved in 5 weeks. EEG normalized and MRI showed 
near-100% resolution of white matter lesions in 5 months 
(perhaps over a shorter time period since he missed his fol-
low-up appointments). Whatever pathophysiological mech-
anism is proposed for cocaine-induced TL in our patient 
must explain the evolution and time-course of recovery of 
all clinical and laboratory findings.
Poor outcome in TL has be attributed to ischemic/
hypoxic injury of the white matter resulting in demyelin-
ation and axonal degeneration.24,25 In light of the mild elec-
troclinical abnormalities and rapid clinical recovery 
(5 weeks), ischemic/hypoxic white matter injury is not a 
suitable explanation for TL in our patient. The best patho-
physiologic explanation is cocaine-induced white matter 
inflammation and edema that was not severe enough to 
cause significant ischemic/hypoxic injury of the white mat-
ter, thus sparing our patient persistent neurological deficits. 
Arguably, TL was not complicated by ischemia/hypoxia in 
our patient because inflammation/edema started to regress 
the moment access to cocaine was lost during hospitaliza-
tion. Some authors pointed out the importance of early 
removal of the offending agent in the prognosis of TL.1,26 
Figure 1. Inpatient brain MRI during the acute stage of cocaine-induced toxic leukoencephalopathy (hospital day 3; 8 days after onset 
of symptoms) showed widespread and symmetric T2-FLAIR and DWI hyperintensities in the subcortical white matter with low ADC 
in some areas (restricted diffusion) and high ADC in other areas (T2 shine-through effect). The cerebral cortex was spared and the 
cerebellum, basal ganglia, thalamus, and brainstem were all normal (the latter structures are not shown).
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Figure 3. Outpatient brain MRI performed 5 months after the initial inpatient MRI (compare with Figure 1) showed near-100% 
resolution of subcortical white matter hyperintensity on T2-FLAIR. Diffusion-weighted imaging showed complete resolution of restricted 
diffusion (normal DWI and ADC).
Figure 2. EEG showed mild diffuse slowing with inordinate amounts of arrhythmic asynchronous theta waves mixed with low-voltage 
beta and alpha activity. This finding is a good match with the mild neuropsychiatric manifestations and preservation of consciousness but 
not with the widespread white matter abnormality on MRI. The latter if caused by widespread demyelination or axonal injury would 
result in more prominent slow wave activity. Display parameters: longitudinal bipolar montage (from top to bottom: LT-LP-RP-RT-ECG), 
digital filter bandpass of 1 to 70 Hz, and 60-Hz notch filter turned on; voltage-time scale is superimposed on the tracing.
Mader et al 5
There is also a possibility that the anti-inflammatory anti-
edema effects of prednisone averted the ischemic/hypoxic 
sequelae of inflammation and edema. Some authors have 
already suspected a role for steroids, plasmapheresis, or 
intravenous immunoglobulins in improving the clinical 
outcome of cocaine-induced TL.8,10,12,17
The patient’s brain MRI showed extensive white matter 
disease (T2-FLAIR and DWI hyperintensity) with 
restricted diffusion (low ADC) in some areas but not in 
others (high ADC; Figure 1). Intracellular edema resulting 
from metabolic failure (eg, ischemia/hypoxia) is known as 
cytotoxic edema.27 The term “cytotoxic” is misleading 
since it implies that cell swelling inevitably leads to cell 
death, which is not always true.28 Intracellular edema can 
occur in astrocytes, oligodendrocytes, neurons, and other 
cells in the brain. In fact, astrocytes swell up faster than 
neurons.27 Intramyelinic edema, which is by and large 
reversible, is also described as “cytotoxic.”29 Extracellular 
edema due to breakdown in blood-brain barrier (BBB), 
allowing plasma proteins (mainly albumin) and water to 
enter the extracellular fluid (ECF) space, is known as 
vasogenic edema.30 Another form of extracellular edema, 
known as ionic edema, is characterized by the accumula-
tion of water and ions (not proteins) in the ECF space due 
to increased BBB permeability or due to a rise in fluid 
pressure within the perivascular space or cerebrospinal 
fluid compartment.30,31 Areas of restricted diffusion in the 
patient’s white matter could represent astrocytic, axonal, 
oligodendrocytic, and/or intramyelinic edema. Vasogenic 
edema could have been the reason for the absence of 
restricted diffusion in parts of the white matter with hyper-
intensity. However, extensive vasogenic edema would 
have increased the patient’s intracranial pressure (ICP) 
leading to headache, nausea, and vomiting, or depressed 
sensorium. Since our patient only had mild cognitive defi-
cits and no clear-cut symptoms of increased ICP, ionic 
edema is a more suitable explanation for the white matter 
hyperintensities without restricted diffusion. The original 
classification of cerebral edema—the one that is familiar 
to clinicians—does not include ionic edema. As a matter 
of fact, it is only in recent years that the concept of ionic 
edema has drawn some clinical interest. Both types of 
Figure 4. Outpatient EEG recorded 5 months after recording the initial inpatient EEG (compare with Figure 2) showed normal alpha 
rhythm posteriorly and normal beta activity anteriorly during wakefulness. Display parameters: longitudinal bipolar montage (from top to 
bottom: LT-LP-RP-RT-ECG), digital filter bandpass of 1 to 70 Hz, and 60-Hz notch filter turned on; voltage-time scale is superimposed 
over the tracing.
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brain edema, intracellular and extracellular, can be 
accounted for by cocaine-induced neuroinflammation.
Neurotoxic agents can produce subcortical white matter 
lesions by activating inflammatory processes, by impeding 
substrate delivery and depriving cells of oxygen, glucose, 
thiamine, and so on, or by directly interfering with cell func-
tion (Figure 5). The pathophysiological mechanisms that 
result in white matter lesions interact in complex ways to 
produce white matter lesions with varying degrees of revers-
ibility. Cocaine can induce neuroinflammation, impede met-
abolic substrate delivery via vasoconstriction, and directly 
interfere with cell physiology.23 Microglial cells, astrocytes, 
and pericytes are activated by cocaine-induced impairment 
of autophagy leading to neuroinflammation.32-34 Autophagy 
protects cells from the endoplasmic reticulum stress caused 
by misfolded proteins and other defective products of bio-
synthesis.33,34 By exposing endothelial cells to oxidative 
stress, cocaine can compromise the integrity of the BBB and 
lead to brain edema.35 Cocaine-induced neuroinflammation 
and production of inflammatory mediators can also affect the 
BBB and result in ionic edema, vasogenic edema, reversible 
cell swelling, or cytotoxic edema. When activated by 
cocaine, glial cells produce interleukins and cytokines-
inducing cell migration to the site of injury.23,35 BBB disrup-
tion due to cytokine release and endothelial cell dysfunction 
can facilitate the transmigration of leukocytes and human 
immunodeficiency viruses from the blood to the brain 
parenchyma.36 Cocaine-induced dopamine signaling can 
reduce glutamate reuptake by astrocytes and lead to stimula-
tion of glial and immune cells thus amplifying the inflam-
matory response.37 Apparently, the neuroinflammatory, 
ischemic/hypoxic, and direct neurotoxic effects of cocaine 
interact in complex ways to produce white matter lesions 
with varying degrees of reversibility.
The variability in TL disease severity and prognosis 
depends on the mechanisms of neurotoxicity, the magnitude 
and duration of exposure, the intensity of cellular response 
(based on genetics and previous exposures), and the presence 
of confounding factors, such as other drugs, dehydration, 
metabolic disturbances, and so on. Various pathophysiologi-
cal processes that give rise to white matter lesions may coex-
ist, overlap, or interact such that what could have been a 
Figure 5. Neurotoxic agents give rise to subcortical white matter lesions by activating inflammatory processes, by depriving cells of 
essential metabolic substrates (oxygen, glucose, thiamine, etc), or by directly interfering with cellular functions. Neuroinflammation can 
affect the blood-brain barrier (BBB) directly or through inflammatory mediators and result in ionic edema, vasogenic edema, reversible 
cell swelling, or cytotoxic edema. Interference with substrate/nutrient delivery to cells, as in the case of ischemia, hypoxia, hypoglycemia, 
nutrient deficiency, nutrient diffusion impedance from edema, and so on, can result in metabolic supply-demand imbalance, failure of 
energy metabolism, energy depletion, ion pump failure, and activation of detrimental processes leading to apoptosis or necrosis. These 
pathophysiological processes interact in complex ways to produce white matter lesions with varying degrees of reversibility.
1Antioxidant mechanisms defend the cell against oxidative stress from free radicals.
2Autophagy protects the cell from endoplasmic reticulum (ER) stress due to misfolded proteins.
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reversible injury could become irreversible (Figure 5). For 
example, vasogenic edema increases the capillary-to-cell 
distance and the concentration of albumin in the ECF space 
reducing the rate of effective solute diffusion and interfering 
with nutrient delivery to the cells.30,31 If severe, vasogenic 
edema can trigger a rise in ICP and result in ischemic injury 
and permanent sequela.30,31 While all the mechanisms shown 
in Figure 5 may play a role in cocaine-induced TL, neuroin-
flammation and BBB leakiness resulting in highly reversible 
extracellular and intracellular edema would be the best 
explanation for the toxic effects of cocaine in our patient. 
Full recovery and near-100% resolution of white matter 
lesions on MRI argue against demyelination and axonal 
injury. As mentioned earlier, cocaine avoidance and/or ste-
roid therapy early in the stage of illness may have spared our 
patient the ischemic/hypoxic sequelae of TL.
EEG is often performed in PRES (due to the high proba-
bility of seizures) but not in patients with TL.38 During the 
acute stage of TL, the patient’s EEG showed scattered theta 
waves. Five months later, his EEG was completely normal. 
Since it took him 5 months to return and get a repeat EEG, it 
is possible that EEG normalization occurred earlier, for 
example, around the time his cognition started to normalize. 
As a rule, EEG is not very useful in the investigation of brain 
edema because water accumulation in the ECF space has 
minimal or no effects on the EEG.39 Indeed, vasogenic edema 
will affect the EEG only if there is significant ICP elevation 
or parenchymal injury.40 On the other hand, cytotoxic edema 
will almost always affect the EEG. These basic principles 
imply that EEG can be useful in the workup of acute diffuse 
leukoencephalopathy because it can provide the clinician 
with some clues regarding the dominant mechanism respon-
sible for the white matter disease. No EEG change or mini-
mal slowing (as in the case presented) would suggest white 
matter edema, whereas substantial slow wave activity, often 
with polymorphic morphology, would indicate demyelin-
ation/axonal injury.41 EEG should be utilized in TL for this 
reason, as well as for detecting nonconvulsive status epilep-
ticus and for tracking recovery of brain function during the 
course of TL.
Conclusion
This case demonstrates that cocaine-induced toxic leukoen-
cephalopathy, even when extensive, does not preclude full 
functional recovery if the electroclinical profile is favor-
able, if cocaine is stopped immediately, and (perhaps) if 
immunotherapy is administered early in the course of the 
disease. The time course of clinical recovery, EEG normal-
ization, and disappearance of MRI lesions in our patient 
suggests that the main pathophysiological mechanism 
underlying toxic leukoencephalopathy was neuroinflam-
mation resulting in extracellular and intracellular white 
matter edema. It also suggests that the extracellular white 
matter edema was predominantly “ionic” due to BBB 
leakiness rather than “vasogenic” due BBB breakdown and 
that the intracellular white matter edema was predomi-
nantly “reversible” glial cell, axonal, and/or intramyelinic 
edema rather than “irreversible” cytotoxic edema due to 
ischemic/hypoxic injury. EEG, which is sensitive to white 
matter disease that disturbs signal transmission along sub-
cortical fiber tracts but barely affected by white matter 
edema, may provide useful adjunctive diagnostic and prog-
nostic information regarding toxic leukoencephalopathy.
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